CAMI - Coalition Advancing Multipurpose Innovations

Draft Agenda

As of 30 September 2011

Primary Objective:  Bring together reproductive health experts to discuss and advance the emerging MPT science, with the goal of providing women around the world with safe, effective, low cost, and user-friendly means of protecting themselves simultaneously from HIV, other sexually transmitted & reproductive tract infections, and/or unintended pregnancy.

Printer Friendly Version (PDF)

Evening Prior to Day 1: Non-hosted reception (venue TBD)

Thursday, November 3

Day 1: Multipurpose prevention technologies: pipeline, progress & recommendations

8:00 – 8:30

Continental Breakfast

 

8:30

Welcome

Bethany Young Holt &

Program Committee

9:50 – 10:10

Break

 

10:10 – 12:15

 

 

      

Panel Discussion 1: The MPT Roadmap so far

  • Outcomes of the May Think Tank Meeting

  • Presentation of the TPP for ‘Drug-Drug &Drug-Device MPTs’

  • Bill and Melinda Gates Foundation Dual Protection Initiative

  • Presentation of the TPP for ‘MPT Vaccines’

Facilitated Discussion

Session Chair:

  • Polly Harrison (AVAC/IMPT)

Panelists: 

  • Joe Romano  (MTN)

  • Monica Kerrigan (BMGF)

  • Kevin Whaley (Mapp Biopharmaceutical)

12:15 – 1:30

LUNCH – optional round table discussions

Chairs:

  • Anke Hemmerling (UCSF&CAMI)

  • Wayne Shields (ARHP)

  • Cynthia Woodsong (IPM)

1:30 – 2:40

Panel Discussion 2: Pressing Issues in the Field:
Hormonal Contraception and HIV Acquisition

 

Session Chair:

  • Helen Rees (Univ. of Witswatersrand)

Panelists:  

  • Mary Lynn Gaffield (WHO)

  • Yogan Pillay (RSA Nat’l Dept of Health)

  • Chelsea Polis (USAID)

  • Jeff Spieler (USAID)

2:40 – 3:40

Panel Discussion 3: Incorporating the Perspective of Product Developers & Researchers to Ensure Successful MPTs
What are the current available technology options for MPT products?  What are their limitations?  What technology and development gaps need to be addressed?

Session Chair: 

  • Jim Turpin (NIAID)

Panelists*:

  • Gustavo Doncel (CONRAD)

  • Ruth Merkatz (Population Council)

  • Tom Moench (ReProtect)

  • Tom Smith (Auritec Pharmaceutical)

  • Tim Fouts (Profectus Biosciences)

  • Maggie Kilbourne-Brook (PATH)

3:40 – 4:00

BREAK

 

4:00 – 5:00

Panel Discussion 4:  Regulatory Pathways for MPTs

 

Current regulatory pathways for MPTs in different global settings

 

 

Session Chair:

  • Martha Brady (Population Council)

Panelists:

  • Allen Wu (Nanjing University)

  • Tim Farley (formerly WHO)

  • Charu Mullick (USFDA)

  • Jeffrey Roberts (USFDA)

5:00 – 5:15

Conclusion and Wrap-up of Day One

Moderator: TBD

5:45 – 8:00

Reception (Old Ebbitt Grill)
Posters on display and refreshments

 

Friday, November 4

Day 2: Multipurpose Prevention Technologies: Efficiencies, Partnerships & Promise

8:30 – 9:00

Continental Breakfast

 

8:30 – 9:00

Welcome, Review of Day 1 & Goals for Day 2

Program committee   

9:00 – 10:00

Opening Plenary 2:  Introduction of the first MPT: Lessons learned to Facilitate the Successful Introduction of Tenofovir Gel

In light of the successes and failures of introducing other RH products (e.g., female condom, Norplant, Plan B, etc), what factors should be considered to facilitate the successful introduction of Tenofovir gel?

Session Co-Chairs: 

  • Michael Mbizvo (WHO)

  • Mitchell Warren (AVAC)

Panelists*:

  • Martha Brady (Population Council)

  • Sengeziwe Sibeko (CAPRISA)

  • David Stanton (USAID)

10:00 – 10:20

BREAK

 

10:20 – 11:20

Panel Discussion 1:  Integrating End-User and Provider Perspectives into the Development of MPTs

Session Co Chairs: 

  • Elizabeth Bukusi (FACES)

  • Jess Cohen (PATH)

  • Maggie Kilbourne-Brook (PATH)

Panelists: 

  • Cynthia Woodsong (IPM)

  • TBD

11:20 – 12:20

Panel Discussion 2:  Donor Perspectives and the Potential for Public-Private Collaboration on MPTs

Chair:

  • Judy Manning (USAID)

Panelists*:

  • NICHD (TBD)

  • Monica Kerrigan (BMGF)

  • Victoria Hale (Medicines 360)

  • Matthew Reeves (WomanCare Global)

  • Mardi Kildebeck (Mary Wohlford)

  • Wellcome Trust  (TBD)

12:20 – 1:30

LUNCH

 

1:30 – 2:15

Panel Discussion 3: Fostering Political Leadership for Product Development

Chair:

  • Wayne Shields (ARHP)

Panelists:

  • Heather Boonstra (Guttmacher Inst.)

  • Michael Stebbins* (White House)

  • TBD (Chinese government)

  • TBD (South African government)

1:30 – 4:30

The Road Forward

2:15-3:00

Session Chairs present highlight, specific next steps and action items needed to advance the scientific agenda for MPTs

3:00-3:15
Transitioning to the MPT London meeting, early 2012

3:15 – 3:20
Closing remarks

Moderators: 

  • Bethany Young Holt (CAMI)

  • Polly Harrison (AVAC/IMPT)

Session Chairs

  • Alan Stone (MEDSA/IMPT)

  • Bethany Young Holt (CAMI/IMPT)

3:20 – 3:40

BREAK

 

3:40 – 4:30

MPT Regional Charters: Mapping regional work plans

Moderator:

  • Alan Stone (MEDSA/IMPT)

4:30

Wrap up & Adjourn

 

4:40 – 5:30

IMPT – next steps (CLOSED MEETING)

IMPT Core Team

*Invited